Our Recommendations
New Publications
- NTDs Part 1: Buruli Ulcer, Chagas, Leishmaniasis (2024)
- Manual de procedimientos para la vigilancia y el control de las leishmaniasis en la Región de las Américas (2023)
- Leishmaniosis outreach posters (2023)
- Leishmaniasis - WHO Website (2023)
- LEISHMANIASIS - ciclo de vida, fisiopatología, diagnóstico y tratamiento {PARTE 1} - YouTube (2023)
Filter
92
Featured
New Publications
5
Language
Document type
Studies & Reports
35
Videos
20
Resource Platforms
14
Fact sheets
7
Infographics
5
Guidelines
4
Strategic & Response Plan
3
Manuals
2
Dashboards/Maps
1
Online Courses
1
Countries / Regions
Global
48
Latin America and the Carribbean
7
Middle East and North Africa
5
Sudan
4
Asia
3
Bangladesh
3
Brazil
3
Ethiopia
3
South Sudan
3
India
3
Kenya
2
Africa
2
Greece
2
Somalia
2
Nepal
1
Mexico
1
Turkey
1
China
1
Syria
1
Iran
1
Albania
1
Senegal
1
Morocco
1
Jordan
1
Saudi Arabia
1
West and Central Africa
1
South–East Asia Region
1
Western and Central Europe
1
North America
1
Tunisia
1
East and Southern Africa
1
Southern Africa
1
Lebanon
1
Eastern Europe
1
Georgia
1
Iraq
1
Pakistan
1
Authors & Publishers
Publication Years
Category
Leishmaniasis
23
Disease Prevention & Control
15
Health System Strengthening
3
Studies & Reports
3
NTDs & Others
3
Pharmacy & Technologies
3
Vector Control
2
Chagas
2
Information, Education and Communication (IEC)
2
Buruli Ulcer
1
Gender
1
x MEDBOX Issue Brief & Annual Reports x
1
Guidelines
1
Parasitology
1
Toolboxes
Information & Education Material (IEC)
28
Studies & Reports
28
Leishmaniasis
18
Statistics & Facts
13
Clinical Aspects & Diagnostics
10
Capacity Building & Resources
9
Vector control
6
NTDs General
4
Overview, Studies & Reports
4
General documents One Health
2
Pharmacy
1
Essential Medicines
1
Capacity Building & Resources
1
Clinical Aspects & Diagnostics
1
Clinical Aspects & Diagnostics
1
Information & Education Material (IEC)
1
Statistics & Facts
1
Statistics & Facts
1
Studies & Reports
1
This article considers the current public health perspective on cutaneous leishmaniasis (CL) and its implications for incidence, prevalence, and global burden of disease calculations. CL is the most common form of leishmaniasis and one of a small number of infectious diseases increasing in incidence...
American cutaneous leishmaniasis (CL) is a severely understudied and neglected“disease of poverty” widespread throughout Peru. Transmission dynamics of CL are complex, requiring sandfly vectors and mammalian reservoir hosts to maintain the pathogen in a local environment whereby incidental hosts...
Leishmaniasis is a major vector-borne disease caused by obligate intramacrophage protozoa of the genus Leishmania, and transmitted by the bite of phlebotomine female sand flies of the genera Phlebotomus and Lutzomyia, in the old and new worlds, respectively. Among 20 well-recognized Leishmania speci...
Cutaneous leishmaniasis (CL) is a parasitic disease caused by infection with a vector-borne protozoan parasite of the genus Leishmania spp. The parasite is transmitted by the bite of an infected phlebotomine sand fly. Infection results in skin lesions which take a long time to heal and may leave per...
Based on categories related to structure, content, language, and illustrations, the present study provides an evaluation of the quality of educational materials on leishmaniasis available to health services in Brazil. The 18 publications evaluated consisted of four handbooks, four guided studies, fo...
Leishmaniasis is a vector-borne disease with a wide variety of parasite species, reservoirs, and vectors involved in transmission. It is caused by different species of the protozoa Leishmania and is transmitted to animals and humans through a bite of insects in the Psychodidae family. Its presence i...
Leishmaniasis is an infectious disease caused by protozoan parasites of the genus, Leishmania. Protozoa are microscopic, single-celled organisms. The parasites that cause the disease are transmitted to people through the bites of certain species of infected sand flies.
In the Indian state of Bihar, visceral leishmaniasis (VL) is a major public health issue that has been aggravated by the rising incidence of new Human immunodeficiency virus (HIV) infections. In endemic areas, the risk of VL infections in patients living with HIV (PLHIV) is higher. It is important t...
Leishmaniases are a group of diseases of zoonotic importance caused by over 20 species of protozoa of the genus Leishmania, in which domestic dogs are considered to be the main reservoir for the disease. However, the involvement of other vertebrates as reservoirs for these parasites has also been in...
Leishmaniasis is found in people in focal areas of approximately 90 countries in the tropics, subtropics, and southern Europe. The ecologic settings range from rain forests to deserts. Leishmaniasis usually is more common in rural than in urban areas, but it is found in the outskirts of some cities...
There is an urgent need to build Research and Development (R&D) capacity for leishmaniasis and other neglected tropical diseases (NTDs) in the Middle East and North Africa. The neglected tropical diseases are a group of 17 viral, bacterial, protozoan, and helminthic infections that often have high m...
A group of enzootic and zoonotic protozoan infections, the leishmaniases constitute among the most severely neglected tropical diseases (NTDs) and are found in all continents except Oceania. Representing the most common infectious diseases, NTDs comprise an open-ended list of some 20 parasitic, bact...
Visceral leishmaniasis, the most severe form of leishmaniasis also known as kala-azar, is a life-threatening disease caused by Leishmania parasites which are transmitted by female sandflies. Visceral leishmaniasis causes fever, weight loss, spleen and liver enlargement, and, if not treated, death. P...
Leishmaniasis is a vector-borne disease with a broad global distribution and an increasing number of recorded cases worldwide. However, it is still one of the world's most neglected diseases. Over the last decades, the disease has been found to expand geographically with a global increase of cases o...
The boundaries and names shown and the designations used on this map do not imply
the expression of any opinion whatsoever on the part of the World Health Organization
concerning the legal status of any country, territory, city or area or of its authorites, or
concerning the delimitation of its f...
Each year 1–2 million people are diagnosed with a tropical disease called leishmaniasis, which is caused by single-celled parasites. People are infected when they are bitten by sandflies carrying the parasite, and often develop skin lesions around the bite site. Though mild cases may recover on th...
Leishmaniasis is still considered to be a global health problem, which spreads in most countries in the world. Leishmania is an intracellular obligate protistan parasite that causes different clinical symptoms in infected humans and other animals. There are clinically different types of the disease ...
We developed an integrated vector surveillance (IVS) proposal for cutaneous leishmaniasis (CL) and visceral leishmaniasis (VL) in the Americas, based on eco-epidemiological studies conducted by researchers of the Leishmaniasis Research Network of Argentina. For CL, the transmission was explained in ...
1 billion people are at risk of infection with leishmaniasis, a neglected disease strongly linked to poverty. There’s no single, simple cure: current treatments are complex and need to be adapted to the form of the disease and geographical region.
Cutaneous Leishmaniasis (CL) is a painful disease that exerts a serious toll on societies around the world that are afflicted by it. Although not life-threatening, the skin ulcers and scars it causes can lead to isolation and psychosocial pathologies due to social stigma, and its occurrence is often...
